![]() |
市場調查報告書
商品編碼
1383466
到 2030 年金奈米顆粒市場預測:按類型、應用、最終用戶和地區分類的全球分析Gold Nanoparticles Market Forecasts to 2030 - Global Analysis By Type, Application, End User and by Geography |
根據Stratistics MRC的數據,2023年全球金奈米顆粒市場規模為38.1億美元,預計2030年將達到98.9億美元,預測期內年複合成長率為14.6%。
金奈米顆粒是一種用途廣泛、研究廣泛的奈米材料,典型尺寸範圍為 1 至 100 奈米。它們獨特的光學特性,包括與尺寸和形狀相關的明亮顏色,使其可用於成像、藥物傳輸和醫療診斷。這些奈米顆粒因其生物相容性而受到高度重視,可實現標靶治療和生物感測器。
根據美國測試與材料協會 (ASTM International 2006) 的說法,奈米顆粒是具有二維或更多維度且尺寸範圍為 1 至 100 nm 的顆粒。
隨著空氣和水污染等環境問題的日益嚴重,金奈米顆粒越來越受歡迎。金奈米顆粒用於許多環境應用,例如空氣污染監測和水淨化。此外,金奈米粒子催化污染物分解的能力及其在環境毒素檢測感測器中的應用與世界對環境保護和永續性的關注相一致。
原料成本、能源使用和合成技術的難度是影響金奈米顆粒製造成本的一些變數。由於特殊應用需要精確控制尺寸和形狀,因此製造成本很高。此外,由於在大批量生產中保持品質和粒度分佈一致性的技術挑戰,實現規模經濟可能很困難。對成本敏感的行業和應用的採用可能會受到此成本因素的限制。
使用金奈米粒子在醫學領域有很多可能性。其特殊的性質可以實現藥物的靶向輸送,從而實現精確的藥物輸送,同時減少副作用。它也是疾病早期診斷和檢測的有用工具,特別是感染疾病和癌症的診斷。此外,隨著醫學研究的進步,金奈米粒子有可能透過提高治療效果和診斷準確性來徹底改變醫療保健。
金奈米顆粒面臨的主要競爭威脅之一是開發具有可比或更好性能但成本更低的替代奈米材料。而且,量子點、奈米銀、碳基奈米材料等材料都有可能改變消費者的需求,所以企業不斷想出新的想法,宣傳奈米金的特殊好處,我必須繼續下去。
金奈米顆粒市場受到了 COVID-19大流行的各種影響。一方面,由於疫苗輸送和診斷等醫療和診斷應用對金奈米顆粒的需求不斷增加,市場不斷成長。即使在疫情過後,金奈米粒子的市場預計仍將擴大,特別是在環境和醫療保健產業。然而,要警惕供應鏈的弱點和經濟的不可預測性。
藥物傳輸領域預計將佔據最大的市場佔有率。金奈米顆粒的特殊性質使其在藥物傳輸應用中非常受歡迎。透過設計這些奈米粒子,可以將治療藥物精確地遞送到特定的細胞和組織。透過對金奈米粒子表面進行功能化,可以提高其生物相容性並延長血液循環。此外,它們的尺寸和形狀可以調整,因此可以客製化以滿足您的特定治療需求。
在金奈米粒子市場中,複合年複合成長率最高的領域是生技公司。金奈米粒子在藥物傳輸、成像、診斷和治療等生物技術應用中越來越普及。金奈米粒子由於其特殊的光學、熱和電特性而非常適合用於生物醫學應用。此外,具有特定配體和生物分子的金奈米顆粒的功能化可以進一步增強其在標靶藥物遞送和成像方面的潛力。
北美,包括美國和加拿大,在金奈米粒子市場中佔據最大佔有率。該地區因其在材料科學、醫療保健和奈米技術方面強大的研發實力而擁有強大的市場影響力。此外,由於北美研究機構、製藥公司和生物技術公司的努力,對金奈米粒子的需求正在顯著成長。
預計歐洲地區金奈米粒子市場的年複合成長率最高。此外,金奈米粒子具有廣泛的應用,包括成像、藥物傳輸和診斷,而醫療保健和生物技術研究的這些發展是其顯著成長的來源。憑藉對奈米技術研究的大力支持和對創新的奉獻,歐洲有望引領市場擴張。
According to Stratistics MRC, the Global Gold Nanoparticles Market is accounted for $3.81 billion in 2023 and is expected to reach $9.89 billion by 2030 growing at a CAGR of 14.6% during the forecast period. Gold nanoparticles are a versatile and widely studied nanomaterial, with typical sizes ranging from 1 to 100 nanometers. Their unique optical characteristics, such as their size- and shape-dependent vivid colors, make them useful for imaging, medication delivery, and medical diagnostics. Due to their biocompatibility, which enables targeted treatments and biosensors, these nanoparticles are highly valued.
According to American Society for Testing and Materials (ASTM international 2006), nanoparticles are those particles which have two or more than two dimensions and are in the size range of 1 - 100 nm.
Gold nanoparticles are becoming more popular as environmental concerns-such as air and water pollution-get bigger. They are used in a number of environmental applications, including air pollution monitoring and water purification. Moreover, the ability of gold nanoparticles to catalyze the breakdown of pollutants and their application in environmental toxin detection sensors are in line with the global focus on environmental protection and sustainability.
The cost of raw materials, energy usage, and the difficulty of synthesis techniques are some of the variables that affect the cost of producing gold nanoparticles. Higher production costs result from the need for precise control over size and shape in specialized applications. Furthermore, it can be difficult to achieve economies of scale because it can be technically difficult to maintain consistency in quality and size distribution at higher volumes. Their adoption in cost-sensitive industries and applications may be restricted by this cost factor.
There are a lot of opportunities in the field of medicine with gold nanoparticles. Their special qualities can be used to deliver drugs with precision and fewer side effects by allowing for targeted delivery. They are also useful instruments for early illness diagnosis and detection, particularly in the diagnosis of infectious diseases and cancer. Additionally, gold nanoparticles have the potential to completely transform healthcare as medical research progresses by increasing treatment efficacy and diagnostic precision.
One major competitive threat to gold nanoparticles is the development of substitute nanomaterials with comparable or better properties but at a lower price. Moreover, materials like quantum dots, silver nanoparticles, and carbon-based nanomaterials can change consumer demand, which forces businesses to keep coming up with new ideas and showcasing the special benefits of gold nanoparticles.
The market for gold nanoparticles has been affected by the COVID-19 pandemic in many ways. On the one hand, the market was growing due to the increase in demand for gold nanoparticles in medical and diagnostic applications, such as vaccine delivery and diagnostics. The market for gold nanoparticles is anticipated to expand after the pandemic passes, especially in the environmental and healthcare industries. However, caution should be exercised regarding supply chain weaknesses and economic unpredictability.
The drug delivery segment is anticipated to hold the largest share in the market. The special qualities of gold nanoparticles have made them very popular in drug delivery applications. Therapeutic agents can be precisely delivered to particular cells or tissues by engineering these nanoparticles. It is possible to functionalize the surface of gold nanoparticles to improve their biocompatibility and lengthen their bloodstream circulation. Furthermore, they can be customized to meet specific therapeutic needs thanks to their adjustable size and shape.
In the market for gold nanoparticles, the segment with the highest CAGR is biotechnology companies. Gold nanoparticles are becoming more and more popular in biotechnology applications such as drug delivery, imaging, diagnostics, and therapeutics. Gold nanoparticles are ideal for use in biomedical applications because of their special optical, thermal, and electrical characteristics. Moreover, the potential of gold nanoparticles in targeted drug delivery and imaging can be further enhanced by functionalizing them with particular ligands and biomolecules.
North America, which includes both the United States and Canada, holds the largest share of the market for gold nanoparticles. Due to the region's intense research and development efforts in material science, healthcare, and nanotechnology, it has a strong market presence. Moreover, the demand for gold nanoparticles has grown significantly, in large part due to the efforts of research institutions, pharmaceutical companies, and biotechnology firms in North America.
In the market for gold nanoparticles, the European region is anticipated to have the highest CAGR. Additionally, gold nanoparticles find wide-ranging applications in imaging, drug delivery, and diagnostics; these developments in healthcare and biotechnology research are the source of this noteworthy growth. With its strong support for nanotechnology research and its dedication to innovation, Europe is well-positioned to lead the way in propelling market expansion.
Some of the key players in Gold Nanoparticles market include: NanoComposix , Agilent Technologies Inc., Expedeon Ltd., BBI Solutions, NanoHybrids Inc, Meliorum Technologies Inc, Cline Scientific, Nanopartz Inc, Goldsol Inc, Abcam plc, Merck Group, Cytodiagnostics Inc, Nanosphere Inc, Metalor Technologies International, Solaris Nanosciences Corporation , Sigma-Aldrich , Tanaka Holdings Co., Ltd, Sona Nanotech Inc and Strem Chemicals Inc.
In October2023, TANAKA, a core company of the TANAKA Precious Metals Group, has developed a high-entropy alloy powder composed entirely of precious metals with a fine particle size of 10um or less, high crystallinity and excellent composition uniformity. This is the world's first high-entropy alloy powder composed entirely of five precious metals: platinum, palladium, iridium, ruthenium, and rhodium. TANAKA has established a mass production process and will provide samples in October.
In March 2023, Agilent Technologies Inc. announced a multi-year distribution agreement with Proscia, a leader in digital pathology to offer a comprehensive digital diagnostic pathology system. Combining Agilent's trusted pathology staining solutions with Proscia's Concentriq Dx enterprise pathology platform will empower pathology labs to transform diagnostic efficiency and quality to improve patient health outcomes.
In May 2020, NanoComposix has established a partnership with Amplicon Biotech to expand access for customers across India to the suite of products and services offered by nanoComposix, a manufacturer of a variety of nanoparticle products for use in lateral flow assays, drug delivery, anti-microbials, optical displays, among other applications.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.